Found 36 matching trials
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies PHASE1 This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Show More Location
Honor Health (GIST, mastocytosis, other solid tumors)
Learn More & Join Trial
Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) N/A In randomised phase III cancer clinical trials, the most objectively define...
Show More Status
Active Not Recruiting
Location
Institut Bergonié
Learn More & Join Trial
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) PHASE2 This phase II trial studies the effect of rogaratinib in treating patients ...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST PHASE2 This is an open label, single arm, phase 2 trial investigating bezuclastini...
Show More Status
Active Not Recruiting
Location
Sylvester Comprehensive Cancer Center, University of Miami
Learn More & Join Trial
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma PHASE1 RATIONALE: STI571 may interfere with the growth of cancer cells and may be ...
Show More Location
Universitair Ziekenhuis Antwerpen
Learn More & Join Trial
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor PHASE2 This phase II trial is studying how well CCI-779 works in treating patients...
Show More Learn More & Join Trial
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer PHASE1 RATIONALE: PV701 may be able to kill tumor cells while leaving normal cells...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Treatment of Patients With RAD001 With Progressive Sarcoma PHASE2 The purpose of this multicenter, three-arm, exact binomial single-stage, ph...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain PHASE3 This is a phase III, randomized, double-blind, placebo-controlled, multicen...
Show More Location
InSys Therapeutics, Incorporated
Learn More & Join Trial
Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma PHASE2 This is an open label single site Phase II clinical trial to identify a pot...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial